Our team
Home > Our team

Chen Xiang

2026-08-06



Chen Xiang

PROFESSIONAL PROFILE

Chen Xiang

Patent Agent  |  Biomedical Patent Professional

He has 10 years of experience in intellectual property practice. His work focuses on drafting patent applications, responding to office actions, patent review and planning, patent searches and patent invalidation matters in the fields of biology, chemistry, pharmaceuticals and medical devices. He has extensive experience in patent protection in the biomedical field.




Professional Qualifications

Patent Agent.

 

Education

Master of Science from Shanghai Jiao Tong University with a focus on biology.


Areas of Practice

He focuses on drafting patent applications, responding to office actions, patent review and planning, patent searches and patent invalidation matters in the fields of biology, chemistry, pharmaceuticals and medical devices. He is familiar with the technical features and patent examination practices relating to biomedicine, chemical pharmaceuticals and medical devices.

In patent drafting and office action responses, he analyzes technical solutions, experimental data, the scope of patent claims and the key points raised by patent examiners. He is able to accurately understand inventive concepts and technical effects and assist clients in improving patent application documents and advancing the examination process.

In patent review and planning, he evaluates research results, product pipelines, core technologies and market application scenarios. He assists clients in identifying innovations with patent protection value and provides focused suggestions on patent filing and portfolio planning.

In patent searches and patent invalidation matters, he conducts searches, comparisons and analysis based on the relevant technology, patent claims and prior art. His work supports patent applications, patent stability reviews, risk assessments and intellectual property disputes.





Technical Fields




ImmunotherapyGenetic TestingDrug TargetsProtein Therapeutics
Natural MedicinesChemical PharmaceuticalsChemical CompoundsMedical Devices

Representative Cases

1. Participated in the representation of Professor Wang Zhaoyin's research group at the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, in a series of patent matters relating to IDO inhibitors. The relevant patent portfolio was subsequently transferred to Innovent Biologics in a transaction valued at USD 475 million.

2. Represented Cellular Biomedicine Group in a series of CAR-T patent matters and obtained the first Chinese patent granted for anti-CD20 CAR-T technology.

3. Represented Tianhao Biotechnology in a core patent project concerning multiplex nucleic acid analysis. The relevant Chinese patent application was initially rejected but was ultimately granted following reexamination proceedings.



Selected Clients


CompaniesDaan Gene, BGI, Xiangxue Pharmaceutical, Shanghai Green Valley Pharmaceutical, Innovent Biologics, Tianhao Biotechnology, GeneChem and other companies.
Universities and Research InstitutionsYale University, University of California, Shanghai Jiao Tong University, Fudan University, Shanghai Institutes for Biological Sciences of the Chinese Academy of Sciences, Shanghai Institute of Nutrition and Health of the Chinese Academy of Sciences, Shanghai Institute of Organic Chemistry of the Chinese Academy of Sciences, Shanghai Institute of Materia Medica of the Chinese Academy of Sciences, Institut Pasteur of Shanghai of the Chinese Academy of Sciences and other universities and research institutions.
© 2026 Shanghai GOOIP Co.,LTD  All Rights Reserved.